77.9 F
San Diego
Tuesday, Sep 27, 2022
-Advertisement-

Vital Therapies Receives $28M in Financing

Vital Therapies Inc., a private, San Diego-based company developing a device to help people suffering from serious liver disease, said Sept. 12 that it has obtained $28.1 million in Series C financing.

The capital will go toward continued development of the Extracorporeal Liver Assist Device , the world’s only human cell-based artificial liver. The new financing was led by Versant Ventures, Delphi Ventures, HBM BioMed China and DFJ DragonFund China.

, Andrew Schweizer

-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-
-Advertisement-